Type 2 diabetes Nutritional, Metabolic, Endocrine Type 2 diabetes mellitus
Conditions
Interventions
Each participant is asked to provide a 2 ml urine sample. Acetone in the headspace of urine in sealed bottles is quantitatively analyzed by mass spectrometry.
Sponsors
Hefei Institutes of Physical Science
Second Hospital of Anhui Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. All T2D patients diagnosed in each hospital and found to have abnormal high fasting plasma glucose (FPG) levels less than 1 week before the experiments 2. Healthy subjects chosen from people undergoing health examinations in these hospitals 3. Age range: 18-90 years
Exclusion criteria
Exclusion criteria: Participants in the healthy control group are required to have no neurological, endocrine or other systemic diseases and no acute and chronic inflammatory or infectious diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary acetone is measured using proton transfer reaction mass spectrometry in less than 8 h after sampling | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Fasting blood glucose is detected using a blood glucose monitor in less than 4 h after sampling 2. A1c is detected using a glycosylated hemoglobin automatic analyzer in less than 4 h after sampling | — |
Countries
China
Outcome results
None listed